Regeneron Pharmaceuticals Inc. Stock Rises Monday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) inched 0.33% higher to $690.33 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.57% to 4,296.12 and the Dow Jones Industrial Average rising 0.70% to 34,049.46. The stock's rise snapped a two-day losing streak. Regeneron Pharmaceuticals Inc. closed $57.09 short of its 52-week high ($747.42), which the company achieved on April 8th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) rose 2.46% to $186.01, Novartis AG ADR (NOVN.EB) rose 1.38% to $90.44, and Amgen Inc. (AMGN) rose 0.73% to $252.17. Trading volume (513,723) remained 147,408 below its 50-day average volume of 661,131.
Data source: Dow Jones Market Data, FactSet. Data compiled April 25, 2022.
-MarketWatch Automation
(END) Dow Jones Newswires
April 25, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.